Update date
13 Apr 2026
Nano Labs Ltd financial metrics
Period Q4 2025 · Filed 13 Apr 2026
Supporting Metrics
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY relative change |
|---|---|---|
| Accounts Payable, Current |
$2,763,577
Period-end balance · 31 Dec 2025
|
+9.7% |
| Accounts Receivable, after Allowance for Credit Loss, Current |
$40,042
Period-end balance · 31 Dec 2025
|
-50% |
| Accumulated Other Comprehensive Income (Loss), Net of Tax |
-$1,059,995
Period-end balance · 31 Dec 2025
|
-188% |
| Assets |
$159,273,894
Period-end balance · 31 Dec 2025
|
+86% |
| Assets, Current |
$61,299,941
Period-end balance · 31 Dec 2025
|
+20% |
| Cash and Cash Equivalents, at Carrying Value |
$1,209,646
Period-end balance · 31 Dec 2025
|
-73% |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$1,401,399
Period-end balance · 31 Dec 2025
|
-70% |
| Common Stock, Par or Stated Value Per Share |
0.002
Period-end balance · 31 Dec 2025
|
0% |
| Contract with Customer, Liability, Current |
¥69,314,154
Period-end balance · 31 Dec 2025
|
-30% |
| Deferred Tax Assets, Gross |
¥165,724,739
Period-end balance · 31 Dec 2025
|
+4.3% |
| Deferred Tax Assets, Operating Loss Carryforwards |
¥118,846,734
Period-end balance · 31 Dec 2025
|
+20% |
| Deferred Tax Assets, Valuation Allowance |
¥165,724,739
Period-end balance · 31 Dec 2025
|
+4.3% |
| Inventory, Net |
$1,948,181
Period-end balance · 31 Dec 2025
|
-53% |
| Lessee, Operating Lease, Liability, to be Paid |
¥3,068,170
Period-end balance · 31 Dec 2025
|
-42% |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
¥1,274,602
Period-end balance · 31 Dec 2025
|
-41% |
| Lessee, Operating Lease, Liability, to be Paid, Year Three |
¥602,087
Period-end balance · 31 Dec 2025
|
-50% |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
¥1,191,481
Period-end balance · 31 Dec 2025
|
-13% |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
¥245,746
Period-end balance · 31 Dec 2025
|
-50% |
| Liabilities |
$53,864,974
Period-end balance · 31 Dec 2025
|
+1.1% |
| Liabilities and Equity |
$159,273,894
Period-end balance · 31 Dec 2025
|
+86% |
| Liabilities, Current |
$29,308,921
Period-end balance · 31 Dec 2025
|
+0.6% |
| Operating Lease, Liability |
¥2,822,424
Period-end balance · 31 Dec 2025
|
-42% |
| Operating Lease, Liability, Current |
$160,152
Period-end balance · 31 Dec 2025
|
-40% |
| Operating Lease, Liability, Noncurrent |
$241,400
Period-end balance · 31 Dec 2025
|
-41% |
| Operating Lease, Right-of-Use Asset |
$439,741
Period-end balance · 31 Dec 2025
|
-39% |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.0624
Period-end balance · 31 Dec 2025
|
0% |
| Other Assets, Current |
$1,288,665
Period-end balance · 31 Dec 2025
|
-83% |
| Property, Plant and Equipment, Net |
$25,983,194
Period-end balance · 31 Dec 2025
|
-5.4% |
| Retained Earnings (Accumulated Deficit) |
-$61,141,689
Period-end balance · 31 Dec 2025
|
+22% |
| Stockholders' Equity Attributable to Parent |
$106,461,123
Period-end balance · 31 Dec 2025
|
+232% |
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
$105,408,920
Period-end balance · 31 Dec 2025
|
+225% |
Comparisons, sources and research notes
Sources and sharing
NA - Nano Labs Ltd Financial Facts
- Context
- Latest metrics period: Q4 2025
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Tracking and update notes
Why revisit this company facts page
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
- Latest source-backed update
- Latest metrics period Q4 2025
- Why come back
- Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
- Current latest metrics period: Q4 2025.
- Most recent SEC facts end date on this page: 31 Dec 2025.
- Save this filer to return when the next filing-backed metric period changes the picture.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest update for NA - Nano Labs Ltd
Latest financial period: Q4 2025. Reopen this facts page to verify the newest reported period against the prior baseline.
Page type
Company facts
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 13 Apr 2026.
Filing notes and source
Key facts
- NA - Nano Labs Ltd financial facts use SEC filings; any third-party reference is labeled separately.
- Latest metrics period on this page: Q4 2025.
- Headline metric summary will appear when SEC facts are available.
Change
- No metrics are currently available for comparison on this facts page.
- Changes will populate automatically as new 10-Q/10-K periods are processed.
Research use
- This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
- Metric cards link to SEC history; a third-party reference may use a different or unverified reporting period.
Evidence
Based on latest 10-Q/10-K
View source filing
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Valuation Snapshot
SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.
DCF value materially below price
Overvalued
Low confidence
-691%
fair value gap
USD inputs only. Cash and complete debt must share the latest balance date. Missing balances are unknown, never zero; equity value and market EV remain unavailable until both are verified.
Fair value per share
-$12.82
Market price
$2.17
NA - Local security
PEG ratio
0.4x
P/E 2.2x / growth 5%
EPS CAGR (3Y)
Enterprise value
-$224.42M
Equity value
-$254.63M
DCF fair value scenarios
Bear
-$9.95
- Growth
- 1%
- Discount
- 11%
- Terminal
- 2%
Gap -559%
Base
-$12.82
- Growth
- 4%
- Discount
- 10%
- Terminal
- 2.5%
Gap -691%
Bull
-$17.33
- Growth
- 7%
- Discount
- 9%
- Terminal
- 3%
Gap -899%
Base growth: DCF Growth Assumption.
Key valuation metrics
EV/Revenue
19.1x
Local security market EV / SEC revenue
EV/EBITDA
6.8x
Local security market EV / SEC EBITDA
P/E
2.2x
Local security market price / SEC EPS
P/S
11.2x
Local security market cap / SEC revenue
P/B
0.4x
Local security market cap / SEC equity
PEG
0.4x
P/E / EPS CAGR
Core assumptions
- Projection
- 5 years
- FCF growth
- 4%
- Discount rate
- 10%
- Terminal growth
- 2.5%
SEC fact inputs
- DCF base FCF
- -$15.41M
- Trailing SEC FCF
- Reported FCF
- -$15.41M
- Net income
- $19.27M
- EBITDA
- $10.78M
- Cash
- $1.21M
- Debt
- $31.41M
- Equity
- $106.46M
- Shares
- 19,862,161
Input periods, units and SEC sources
Equity value = DCF enterprise value + cash − debt. Cash flow uses matching annual or trailing-12-month periods.
- Operating cash flow: -15,403,609.0 USD · through 2025-12-31 · reported annual SEC source
- Capital expenditures: 6,585.0 USD · through 2025-12-31 · reported annual SEC source
- Cash and equivalents: 1,209,646.0 USD · through 2025-12-31 SEC source
- Debt: 31,412,593.0 USD · through 2025-12-31 · Borrowings excluding leases SEC source SEC source SEC source
Data confidence notes
- Dcf base free cash flow: trailing free cash flow is not positive
- Dcf confidence is low for this sec-only free cash flow estimate
- Base free cash flow is negative; dcf output is mechanically computed but high risk
- Dcf uses fallback growth assumption because historical free cash flow growth is unavailable
Financial Quality Score
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
n/a
Insufficient Data Confidence low
Financial Health
Calculation methodology and other links
How we score
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
How Calculated (standard_v1)
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
- Operating Income / Revenues using matching TTM or quarter periods; basis shown per metric
- Current Assets / Current Liabilities (latest instant quarter)
- (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
- Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
- TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
- TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
- TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
- Revenues YoY using available TTM or quarter comparison; basis shown per metric
- Net Income YoY using available TTM or quarter comparison; basis shown per metric
CIK / security context first